Impact of mass testing during an epidemic rebound of SARS-CoV-2: a modelling study using the example of France.
Covid-19
SARS-CoV-2
epidemic
mass testing
Journal
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin
ISSN: 1560-7917
Titre abrégé: Euro Surveill
Pays: Sweden
ID NLM: 100887452
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
entrez:
8
1
2021
pubmed:
9
1
2021
medline:
26
1
2021
Statut:
ppublish
Résumé
We used a mathematical model to evaluate the impact of mass testing in the control of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Under optimistic assumptions, one round of mass testing may reduce daily infections by up to 20-30%. Consequently, very frequent testing would be required to control a quickly growing epidemic if other control measures were to be relaxed. Mass testing is most relevant when epidemic growth remains limited through a combination of interventions.
Identifiants
pubmed: 33413741
doi: 10.2807/1560-7917.ES.2020.26.1.2001978
pmc: PMC7791601
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM